Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Case 3 - The depressed bipolar patient on multiple medications
Published online by Cambridge University Press: 19 October 2021
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Summary
Pretest self-assessment question (answer at the end of the case)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 25 - 36Publisher: Cambridge University PressPrint publication year: 2021
References
Allison, DB, Mentore, JL, Heo, M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156:1686–96. https://doi.org/10.1176/ajp.156.11.1686CrossRefGoogle ScholarPubMed
Biton, V, Mirza, W, Montouris, G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001; 56:172–7. https://doi.org/10.1212/wnl.56.2.172CrossRefGoogle ScholarPubMed
Bowden, CL, Calabrese, JR, McElroy, SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57:481–9. https://doi.org/10.1001/archpsyc.57.5.481CrossRefGoogle ScholarPubMed
Bozzatello, P, Brignolo, E, de Grandi, E, Bellino, S. Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data. J Clin Med 2016; 5:67. https://doi.org/10.3390/jcm5080067CrossRefGoogle ScholarPubMed
Calabrese, JR, Sullivan, JR, Bowden, CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 2002; 63:1012–19. https://doi.org/10.4088/jcp.v63n1110CrossRefGoogle ScholarPubMed
Carvalho, AF, Firth, J, Vieta, E. Bipolar disorder. N Engl J Med 2020; 383:58–66. https://doi.org/10.1056/NEJMra1906193CrossRefGoogle ScholarPubMed
Chengappa, KNR, Rathore, D, Levine, J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999; 1:42–53. https://doi.org/10.1034/j.1399-5618.1999.10111.xCrossRefGoogle ScholarPubMed
Dunner, DL. Optimizing lithium treatment. J Clin Psychiatry 2000; 61 (Suppl. 9):76–81.Google ScholarPubMed
Fountoulakis, KN, Grunze, H, Vieta, E, et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines. Int J Neuropsychopharmacol 2017; 20:180–95. https://doi.org/10.1093/ijnp/pyw109Google ScholarPubMed
Frye, MA, Ketter, TA, Kimbrell, TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607–14. https://doi.org/10.1097/00004714-200012000-00004CrossRefGoogle ScholarPubMed
Gidal, BE, Maly, MM, Nemire, RE, Haley, K. Weight gain and gabapentin therapy. Ann Pharmacother 1995; 29:1048. https://doi.org/10.1177/106002809502901019CrossRefGoogle ScholarPubMed
Goodwin, GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346–88. https://doi.org/10.1177/0269881109102919CrossRefGoogle ScholarPubMed
Keck, PE Jr, McElroy, SL. Redefining mood stabilization J Affect Disord 2003; 73:163–9. https://doi.org/10.1016/s0165-0327(01)00355-xCrossRefGoogle ScholarPubMed
Knowles, SR, Shapiro, LE, Shear, NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999; 21:489–501. https://doi.org/10.2165/00002018-199921060-00005CrossRefGoogle ScholarPubMed
Mallinger, AG, Thase, ME, Haskett, R, et al. Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disord 2008; 10:856–66. https://doi.org/10.1111/j.1399-5618.2008.00636.xCrossRefGoogle Scholar
McElroy, S, Suppes, T, Keck, PE Jr, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47:1025–33. https://doi.org/10.1016/s0006-3223(99)00316-9CrossRefGoogle ScholarPubMed
Melkersson, KI, Hulting, A-L, Brismar, KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000; 61:742–9. https://doi.org/10.4088/jcp.v61n1006CrossRefGoogle ScholarPubMed
Rosa, AR, Fountoulakis, K, Siamouli, M, et al. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS Neurosci Ther 2011; 17: 167–77. https://doi.org/10.1111/j.1755-5949.2009.00089.xCrossRefGoogle Scholar
Sanger, TM, Grundy, SL, Gibson, PJ, et al. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 2001; 62:273–81. https://doi.org/10.4088/jcp.v62n0410CrossRefGoogle ScholarPubMed
Schein, F, Manoli, P, Cathébras, P. Lithium-induced downbeat nystagmus. Am J Ophthalmol Case Rep 2017; 7:74–5. https://doi.org/10.1016/j.ajoc.2017.06.012Google ScholarPubMed
Schlienger, RG, Shear, NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39 (Suppl. 7):S3–7. https://doi.org/10.1111/j.1528-1157.1998.tb01678.xCrossRefGoogle ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017.Google Scholar
Tohen, M, Sanger, TM, McElroy, SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156:702–9. https://doi.org/10.1176/ajp.156.5.702CrossRefGoogle ScholarPubMed
Tohen, M, Jacobs, TG, Grundy, SL, et al. for the Olanzapine HGGW Study Group. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57:841–9. https://doi.org/10.1001/archpsyc.57.9.841CrossRefGoogle Scholar
Young, LT, Robb, JC, Patelis-Siotis, I, et al. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42:851–3. https://doi.org/10.1016/s0006-3223(97)00305-3CrossRefGoogle ScholarPubMed